126 related articles for article (PubMed ID: 38676743)
1. Correction to: P53 Overexpression May Represent an Early Marker of Clinicopathologic Progression in Vasculogenic Mesenchymal Lesions of Germ Cell Tumor Origin.
Youssef R; Ulbright TM; Acosta AM
Virchows Arch; 2024 Apr; ():. PubMed ID: 38676743
[No Abstract] [Full Text] [Related]
2. P53 Overexpression May Represent an Early Marker of Clinicopathologic Progression in Vasculogenic Mesenchymal Lesions of Germ Cell Tumor Origin.
Youssef R; Ulbright TM; Acosta AM
Virchows Arch; 2024 Mar; ():. PubMed ID: 38499669
[TBL] [Abstract][Full Text] [Related]
3. Vasculogenic Mesenchymal Tumor: A Clinicopathologic and Molecular Study of 55 Cases of a Distinctive Neoplasm Originating From Mediastinal Yolk Sac Tumor and an Occasional Precursor to Angiosarcoma.
Levy DR; Agaram NP; Kao CS; Franks SE; Kesler KA; Stram AR; Einhorn LH; Bangs CD; Ulbright TM
Am J Surg Pathol; 2021 Apr; 45(4):463-476. PubMed ID: 33136584
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Malignant Mixed Germ Cell Tumor Composed Mainly of a Polyembryoma Pattern With Vasculogenic Mesenchymal Tumor Components.
Kouchi Y; Komatsu S; Harada S; Shinomiya Y; Ikeda JI; Kishimoto T
Int J Gynecol Pathol; 2023 Jan; 42(1):78-82. PubMed ID: 35512212
[TBL] [Abstract][Full Text] [Related]
5. Inverse and reciprocal regulation of p53/p21 and Bmi-1 modulates vasculogenic differentiation of dental pulp stem cells.
Zhang Z; Oh M; Sasaki JI; Nör JE
Cell Death Dis; 2021 Jun; 12(7):644. PubMed ID: 34168122
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of p53 protein and MDM2 in papillary carcinomas of the thyroid: Correlations with clinicopathologic features.
Horie S; Maeta H; Endo K; Ueta T; Takashima K; Terada T
Pathol Int; 2001 Jan; 51(1):11-5. PubMed ID: 11148457
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumours.
Heidenreich A; Schenkman NS; Sesterhenn IA; Mostofi KF; Moul JW; Srivastava S; Engelmann UH
APMIS; 1998 Jan; 106(1):90-9; discussion 99-100. PubMed ID: 9524567
[TBL] [Abstract][Full Text] [Related]
9. A case of vasculogenic mesenchymal tumor in the mediastinum: whole-exome sequencing reveals origin from pre-existing germ cell tumor.
Fujii H; Yamada Y; Yamamura K; Ishida Y; Tsujimura M; Matsumoto K; Tanaka S; Date H; Nishikawa T; Yoshida Y; Kashima J; Yatabe Y; Ogawa S; Marx A; Ulbright TM; Haga H
Virchows Arch; 2023 May; 482(5):923-927. PubMed ID: 36943470
[TBL] [Abstract][Full Text] [Related]
10. Esophageal small cell carcinomas: clinicopathologic parameters, p53 overexpression, proliferation marker, and their impact on pathogenesis.
Lam KY; Law S; Tung PH; Wong J
Arch Pathol Lab Med; 2000 Feb; 124(2):228-33. PubMed ID: 10656731
[TBL] [Abstract][Full Text] [Related]
11. p53: a good diagnostic marker for intratubular germ cell neoplasia, unclassified.
Moore BE; Banner BF; Gokden M; Woda B; Liu Y; Ayala A; Jiang Z
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):203-6. PubMed ID: 11556746
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of STAT3 Promotes Vasculogenic Mimicry by Inducing Epithelial-to-Mesenchymal Transition in Colorectal Cancer.
Han C; Sun B; Zhao X; Zhang Y; Gu Q; Liu F; Zhao N; Wu L
Technol Cancer Res Treat; 2017 Dec; 16(6):1209-1219. PubMed ID: 29333928
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of vasculogenic mimicry in colorectal cancer.
Baeten CI; Hillen F; Pauwels P; de Bruine AP; Baeten CG
Dis Colon Rectum; 2009 Dec; 52(12):2028-35. PubMed ID: 19934926
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and diagnostic significance of p53 protein expression in papillary thyroid carcinoma.
Shin MK; Kim JW
Asian Pac J Cancer Prev; 2014; 15(5):2341-4. PubMed ID: 24716981
[TBL] [Abstract][Full Text] [Related]
15. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
16. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
17. Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary thyroid carcinomas correlated with lymph node metastasis, tumor size and clinicopathologic stage.
Chen BK; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Liang SB; Sonobe H
Int J Oncol; 1999 Nov; 15(5):893-8. PubMed ID: 10536170
[TBL] [Abstract][Full Text] [Related]
18. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.
Sarkis AS; Dalbagni G; Cordon-Cardo C; Zhang ZF; Sheinfeld J; Fair WR; Herr HW; Reuter VE
J Natl Cancer Inst; 1993 Jan; 85(1):53-9. PubMed ID: 7677935
[TBL] [Abstract][Full Text] [Related]
19. "Paradoxical" p16 overexpression in cutaneous melanoma: Molecular and immunohistochemical analysis of a rare phenomenon with a focus on cell cycle regulatory molecules.
Ricci C; Dika E; Corti B; Lambertini M; Ambrosi F; Cappilli S; Grillini M; Filippo GD; Franchini E; Maloberti T; Fiorentino M; Tallini G; Biase D
Pathol Res Pract; 2023 Jul; 247():154564. PubMed ID: 37235909
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.
Popov Z; Hoznek A; Colombel M; Bastuji-Garin S; Lefrere-Belda MA; Bellot J; Abboh CC; Mazerolles C; Chopin DK
Cancer; 1997 Oct; 80(8):1472-81. PubMed ID: 9338472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
